Form 4: OPKO Health CEO Phillip Frost Acquires Additional Shares

OPKO Health's CEO and Chairman, Phillip Frost, through related trusts, acquired 47,537 shares of common stock at a weighted average price of $1.4738 per share.

Summary

• Phillip Frost, CEO and Chairman of OPKO Health, acquired 47,537 shares of common stock on January 28, 2025.
• The shares were purchased at a weighted average price of $1.4738, with individual transactions ranging from $1.465 to $1.475 per share.
• The transaction increased Frost's indirect holdings to 213,234,014 shares through Frost Gamma Investments Trust.
• Frost also directly owns 3,568,951 shares and indirectly owns 30,127,177 shares through Frost Nevada Investments Trust.
• Frost disclaims beneficial ownership of the indirectly held shares except to the extent of any pecuniary interest.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The CEO's purchase of shares is a positive sign, but the document is primarily a routine disclosure of an insider transaction.

Positives

• The CEO's purchase of shares could be seen as a positive signal of confidence in the company's future prospects.
• The purchase increases the CEO's stake in the company, aligning his interests with those of other shareholders.

Risks

• The document does not explicitly state any risks, but it is important to note that insider transactions can sometimes be viewed with scrutiny by the market.
• The disclaimer of beneficial ownership, while standard, could be a point of concern for some investors.

Management Comments

• The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Industry Context

This is a standard SEC Form 4 filing, which is common for publicly traded companies when insiders make transactions in their company's stock. It is a routine disclosure and does not indicate any specific industry trend.

Comparison to Industry Standards

• SEC Form 4 filings are a standard practice for all publicly traded companies in the US.
• The level of detail provided in this filing is consistent with what is expected for insider transactions.
• The disclaimer of beneficial ownership is a common practice in these filings, especially when shares are held through trusts or other entities.

Stakeholder Impact

• The share purchase could positively impact shareholder confidence.
• The transaction does not have any direct impact on employees, customers, suppliers, or creditors.

Key Dates

Keywords

OPKO Health, Phillip Frost, insider trading, share acquisition, common stock, Frost Gamma Investments Trust, Frost Nevada Investments Trust